Analyst Initiates Coverage On Accolade, Says ‘Differentiated In Growing Market’
Raymond James initiated coverage on Accolade Inc (NASDAQ:ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected…
Jim Cramer Says This Stock Is Undervalued: ‘I Think That It’s Coming Back’
On CNBC’s "Mad Money Lightning Round," Jim Cramer he wants to own Sherwin-Williams Co (NYSE: SHW). "Everything that they could possibly say negative about it is out there.
5 Most Expensive Real Estate Stocks You Should Worry About
The most overbought stocks in the real estate sector presents an opportunity to go short on these overvalued companies.
American Airlines, Morgan Stanley And 2 Other Stocks Insiders Are Selling
The Nasdaq jumped by around 2% on Wednesday following the Fed’s rate decision. Investors, meanwhile, focused on some notable insider trades.
Tesla, Amazon, Meta, Carvana, Silvergate Capital: Why These 5 Stocks Are Drawing Investors’ Attention Today
Major Wall Street indices closed in the green on Wednesday after the Federal Reserve dialed down the pace of its rate hike to 25 basis points on expected lines and Chairman Jerome Powell acknowledged inflation<
Allegiant Travel Stock Takes Off On Strong Q4 Earnings, Boeing Planes To Be Delivered In 2023
Las Vegas-based Allegiant Travel Company (NASDAQ: ALGT) shares are trading higher in Wednesday's after-hours session after the company reported better-than-e
US Stocks Turn Higher After Fed Raises Key Overnight Interest Rate; Nasdaq Up 1.5%
U.S. stocks turned higher toward the end of trading, following the release of interest rate decision.
The Dow traded up 0.05% to 34,104.56 while the NASDAQ rose 1.58% to 11,767.44. The S&P 500 also fell, dropping, 0.83% to 4,110.42.
Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics
Cantor Fitzgerald initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a price target of $21. The analyst says…
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
Cantor Fitzgerald initiated coverage on Editas Medicine Inc (NASDAQ:EDIT) with an Overweight rating and a price target of $15. The analyst says…
Dow Dips 300 Points; Snap Shares Plunge
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday.
The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500 also fell, dropping, 0.41% to 4,059.70.